Cambridge Medical Robotics is a private company developing the next-generation universal robotic system for minimal access surgery.
Our vision is to make minimal access (or keyhole) surgery universally accessible and affordable by significantly expanding the range of procedures that can be performed robotically. CMR successfully completed preliminary cadaveric trials in May 2016, which will inform further cadaveric, animal and first-in-human trials.
CMR’s technology will transform the existing market for surgical robotics. Global annual revenues for robot-assisted minimal access surgery are presently approximately $4 billion and are anticipated to reach $20 billion by 2025 ('Industry Forecast, Accuray Research').
Cambridge Medical Robotics has grown rapidly since incorporation in 2014 and has its headquarters in Cambridge, United Kingdom. The company achieved the registration of its Quality Management System to ISO 13485:2003 by Underwriters Laboratories LLC® (‘UL’) and the status as a UL Registered Firm in September 2015.